Completed
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
NCT05483933
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
- Locations
-
- University of Arkansas for Medical sciences Little Rock, Arkansas, United States
- City of Hope Duarte, California, United States
- Robert H.Lurie ComprehensiveCancer Center, Northwestern University Chicago, Illinois, United States
- START Midwest Grand Rapids, Michigan, United States